Showing results (41-50 of 166) with videos related to

Sort By:
Pageof 17
The Journal of Urology|August 25, 2000
Testicular health awareness in pubertal malesP Nasrallah, G Nair, J Congeni, et al.
Seminars in Oncology|March 11, 1999
The effect of reimbursement policies on the management of Medicare patients with refractory ovarian cancerC L Bennett, T J Stinson, T Yang, et al.
Cancer Investigation|April 12, 2001
Economic analysis of amifostine as adjunctive support for patients with advanced head and neck cancer: preliminary results from a randomized phase II clinical trial from GermanyC L Bennett, D Lane, T Stinson, et al.
Transfusion|August 1, 1995
Patterns of care for and outcomes of Pneumocystis carinii pneumonia among persons with transfusion-acquired AIDSC L Bennett, R D Horner, D Aboulafia, et al.
The American Journal of Medicine|December 1, 1986
Hairy cell leukemia and mucormycosis. Treatment with alpha-2 interferonC L Bennett, C A Westbrook, B Gruber, et al.
Cancer Investigation|June 17, 1999
Growth of oncology physician practice management companiesK Mighion, D H Gesme, R M Rifkin, et al.
Seminars in Hematology|February 17, 2000
The potential for treatment of idiopathic thrombocytopenic purpura with anti-D to prevent splenectomy: a predictive cost analysisC L Bennett, P D Weinberg, R M Golub, et al.
Urology|April 1, 1995
Estimating the cost effectiveness of total androgen blockade with flutamide in M1 prostate cancerB E Hillner, D G McLeod, E D Crawford, et al.
Cancer Treatment Reports|September 1, 1986
Hyponatremia and other toxic effects during a phase I trial of recombinant human gamma interferon and vinblastineC L Bennett, N J Vogelzang, M J Ratain, et al.
European Journal of Immunology|March 10, 2001
Silent infection of bone marrow-derived dendritic cells by Leishmania mexicana amastigotesC L Bennett, A Misslitz, L Colledge, et al.
Pageof 17